Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.
about
Effects of curcumin on retinal oxidative stress and inflammation in diabetesEpigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylationOxidative stress and light-evoked responses of the posterior segment in a mouse model of diabetic retinopathy.Therapeutic implications of curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways.MnSOD Val16Ala polymorphism associated with retinopathy risk in diabetes: a PRISMA-compliant Meta-analysis of case-control studies.Oxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathyTherapeutic potential of endothelin receptor antagonists in diabetes.Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.Physiological effects of superoxide dismutase on altered visual function of retinal ganglion cells in db/db miceMitochondrial dysfunction in retinal diseasesTherapeutic potential of anti-oxidants and diabetic retinopathy.Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathyOxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutaseThe pathogenesis of diabetic retinopathy: old concepts and new questions.Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy.Endothelins in chronic diabetic complications.Diabetic retinopathy, superoxide damage and antioxidants.The retina: oxidative stress and diabetes.Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?Catalase therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy.Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathyDiabetic retinopathy and damage to mitochondrial structure and transport machinery.Oxidative stress and diabetic retinopathy.Astaxanthin Inhibits Expression of Retinal Oxidative Stress and Inflammatory Mediators in Streptozotocin-Induced Diabetic Rats.Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patientsGlutathione-related enzymes and the eye.Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia.Impaired transport of mitochondrial transcription factor A (TFAM) and the metabolic memory phenomenon associated with the progression of diabetic retinopathyA compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathyTranscription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathyOxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.Retinal ion regulation in a mouse model of diabetic retinopathy: natural history and the effect of Cu/Zn superoxide dismutase overexpression.Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.Cerium oxide and platinum nanoparticles protect cells from oxidant-mediated apoptosis.Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in diseaseEpigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.The role and therapeutic potential of melatonin in age-related ocular diseases.D-galactose induces necroptotic cell death in neuroblastoma cell lines.Overexpression of Bcl-2 in vascular endothelium inhibits the microvascular lesions of diabetic retinopathy.Effects of pomegranate seed oil on oxidant/antioxidant balance in heart and kidney homogenates and mitochondria of diabetic rats and high glucose-treated H9c2 cell line.
P2860
Q28567589-DBABB6EF-13B9-4383-88C6-18D46C148D30Q28578457-8F5C27F6-FFB1-4913-86EF-C009E6D65AE8Q30883743-F8D0EB66-1E7B-4685-B01C-6227476D2CB2Q31146840-8B2ABDFE-7C39-45A0-9615-E82E799F0BF0Q33607780-25A122E3-B458-4502-B144-4D88EFE4AFE1Q33737370-AAE0E389-D8E6-4777-AB65-EC5F9889963CQ34090982-0A2F6D5A-863B-44C9-AC09-6925386396DFQ34103169-4CB584F7-A0B4-4BB0-96C0-66C3A616ED99Q34137707-37A42BB1-18F5-4565-A2B7-2A61E3D43270Q34221905-A31828B0-F1DC-4E93-A185-8A99229FBDD9Q34481705-F7E32366-2693-4566-9416-F53F37A2B2C2Q34511162-5272661E-E13F-4F3E-A2DF-D5ECA333558DQ34512906-7B97C60B-1E87-4370-9ADE-7CFDAFA9EA9BQ34658478-359AC4C3-1703-44EB-9C47-B27A7A78CB6FQ34718901-E72EA509-6A86-4B29-B4FA-BFD14C7F75DAQ35168430-3D4C879D-4AB8-49C5-93B2-4DA7521227A0Q35545811-EB3D654E-4D79-4D8E-8EF1-DE44606A61E2Q35576292-383E66A4-A6E9-449B-B4D8-D939679D6A4AQ35591570-5E3ED516-BACC-4587-B9E3-7965680B04C9Q35629167-72FA6E33-C8DF-4771-9C61-CA3FBE78A480Q35674614-05CC329C-809A-43A0-9495-C457175A3118Q35687928-C63FFDE4-D324-405A-B158-1EBA287DEEBDQ35819297-D0FFB814-73B5-4C72-8D6E-8ED800A0FCAFQ35893876-49B352F1-40F8-4720-9193-62F545005830Q35919289-472687A5-6704-4C9E-8535-5C77B5B1E1ECQ36371822-F0DB0846-CB94-47D3-A42F-388DFEAAC816Q36486013-9317013F-1E6C-4ABC-9306-C3C9A9B5FBC1Q36681105-78B2E6DE-53F3-4DAC-9A4C-750DC7B91EC2Q36783430-D1B32B45-5C41-45C4-A9CE-40FA22C39D8AQ36911967-42E67531-FDF3-4653-9730-429560DE1634Q37195371-E391FB92-4CDF-4013-9B55-279C7E9CD550Q37206608-693E35F5-97DB-4FBF-AF94-BD1AA4E400E6Q37396370-3F659AD8-5C07-4EDD-A665-CC1AE2FAB97DQ38845584-1DB25364-E402-49FC-9BAC-03A7E5044758Q38944575-2A55D404-E594-4B2B-98C4-676C3D06AC3EQ39052777-A2939E59-E141-4D75-A817-08DDB55806BEQ39402838-D4D6F5A3-E8FA-4F04-BC24-03DA558BCB5FQ39492955-DF2C214A-C160-4808-8274-510512F3E7D5Q40244986-BCC42A63-656E-4B00-8002-A29E7A4CE0A0Q41591727-6A20EEA3-1494-4D14-BE5D-60C944E3C1D3
P2860
Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Abnormalities of retinal metab ...... V. Antioxidant defense system.
@en
Abnormalities of retinal metab ...... V. Antioxidant defense system.
@nl
type
label
Abnormalities of retinal metab ...... V. Antioxidant defense system.
@en
Abnormalities of retinal metab ...... V. Antioxidant defense system.
@nl
prefLabel
Abnormalities of retinal metab ...... V. Antioxidant defense system.
@en
Abnormalities of retinal metab ...... V. Antioxidant defense system.
@nl
P2093
P1476
Abnormalities of retinal metab ...... V. Antioxidant defense system.
@en
P2093
P304
P356
10.1016/S0891-5849(96)00347-4
P577
1997-01-01T00:00:00Z